AM 831Alternative Names: AM831; PCAP programme
Latest Information Update: 18 Jul 2012
At a glance
- Originator ACADIA Pharmaceuticals
- Class Antipsychotics; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Muscarinic M1 receptor agonists; Serotonin 2A receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Schizophrenia